Daiwa Securities Group

Daiwa Securities Group Portfolio holdings

AUM $27.1B
1-Year Return 23.24%
This Quarter Return
+6.66%
1 Year Return
+23.24%
3 Year Return
+64.59%
5 Year Return
+118.48%
10 Year Return
+210.79%
AUM
$15.1B
AUM Growth
+$741M
Cap. Flow
-$213M
Cap. Flow %
-1.41%
Top 10 Hldgs %
36.34%
Holding
1,384
New
57
Increased
578
Reduced
363
Closed
33

Sector Composition

1 Real Estate 54.3%
2 Technology 12.23%
3 Consumer Discretionary 4.83%
4 Communication Services 4.52%
5 Healthcare 4.29%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
VT icon
1226
Vanguard Total World Stock ETF
VT
$51.8B
0
VTI icon
1227
Vanguard Total Stock Market ETF
VTI
$528B
0
PETQ
1228
DELISTED
PetIQ, Inc. Class A Common Stock
PETQ
$2K ﹤0.01%
99
ICPT
1229
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$2K ﹤0.01%
167
VIG icon
1230
Vanguard Dividend Appreciation ETF
VIG
$95.8B
0
ALPN
1231
DELISTED
Alpine Immune Sciences, Inc. Common Stock
ALPN
$1K ﹤0.01%
85
ABOS icon
1232
Acumen Pharmaceuticals
ABOS
$87.2M
$1K ﹤0.01%
165
ABUS icon
1233
Arbutus Biopharma
ABUS
$805M
$1K ﹤0.01%
395
ALLK
1234
DELISTED
Allakos
ALLK
$1K ﹤0.01%
343
ALXO icon
1235
ALX Oncology
ALXO
$65.3M
$1K ﹤0.01%
138
AVIR icon
1236
Atea Pharmaceuticals
AVIR
$267M
$1K ﹤0.01%
242
BCAB icon
1237
BioAtla
BCAB
$31.5M
$1K ﹤0.01%
186
CDXS icon
1238
Codexis
CDXS
$218M
$1K ﹤0.01%
189
CGEM icon
1239
Cullinan Oncology
CGEM
$413M
$1K ﹤0.01%
127
CHRS icon
1240
Coherus Oncology, Inc. Common Stock
CHRS
$150M
$1K ﹤0.01%
262
CMPS
1241
Compass Pathways
CMPS
$493M
$1K ﹤0.01%
64
CNTA
1242
Centessa Pharmaceuticals
CNTA
$2.11B
$1K ﹤0.01%
211
CRBU icon
1243
Caribou Biosciences
CRBU
$174M
$1K ﹤0.01%
176
CSTL icon
1244
Castle Biosciences
CSTL
$683M
$1K ﹤0.01%
86
DSGN icon
1245
Design Therapeutics
DSGN
$367M
$1K ﹤0.01%
162
ENTA icon
1246
Enanta Pharmaceuticals
ENTA
$189M
$1K ﹤0.01%
69
EOLS icon
1247
Evolus
EOLS
$495M
$1K ﹤0.01%
162
ERAS icon
1248
Erasca
ERAS
$457M
$1K ﹤0.01%
354
FGEN icon
1249
FibroGen
FGEN
$48.9M
$1K ﹤0.01%
15
FHTX icon
1250
Foghorn Therapeutics
FHTX
$326M
$1K ﹤0.01%
168